evaluating CK #

Related by string. * Evaluated . EVALUATING . EVALUATED . evaluated . Evaluating : When evaluating Antigenics . rigorously evaluated . evaluating OGX . prospectively evaluated . Intervention Trial Evaluating / Ck . CKS . cks . cked . CKD : F * ck . f * ck . f * cking [002] . af * cking . af * ck / # [012] . # [007] . # [016] . #s [002] . # [014] : #.# ov #-# . #-#:# pm [001] . ID # # . i Newswire #-#-# . Call #-#-# [002] * *

Related by context. Frequent words. (Click for all words.) 64 acute decompensated heart 64 omecamtiv mecarbil 62 Mipomersen 61 NYHA Class II 61 ischemic cardiomyopathy 61 tolvaptan 61 phase IIb clinical 61 liposomal formulation 61 left ventricular dysfunction 60 refractory chronic lymphocytic 60 forodesine 60 Panzem R 60 GGF2 60 Dasatinib 60 Sym# 59 Daclizumab 59 left ventricular systolic 59 Azedra 59 phase IIa clinical 59 ALN TTR# 59 bucindolol 59 paclitaxel eluting stents 59 von Willebrand factor 59 Factor VIIa 59 tumor lysis syndrome 59 ATL# [001] 58 diastolic heart 58 MKC# 58 metastatic castration resistant 58 Laquinimod 58 recurrent glioblastoma 58 C1 INH 58 Pivotal Phase III 58 HGS ETR1 57 irbesartan 57 ELND# 57 prospectively defined 57 elotuzumab 57 Initiate Phase 57 BrachySil 57 secondary hyperparathyroidism 57 lanthanum carbonate 57 Phase Ib clinical 57 beta blocker therapy 57 Epratuzumab 57 humanized anti 57 myocardial ischemia 56 CD# expressing 56 lupus nephritis 56 TAXUS Stent 56 relapsed multiple myeloma 56 NYHA class 56 inhaled nitric oxide 56 pericardial effusion 56 pegylated 56 ReoPro 56 Alemtuzumab 56 Bicifadine 56 surrogate endpoint 56 cardiovascular morbidity 56 Tamibarotene 56 Diabetic Macular Edema 56 ivabradine 56 coagulation factors 56 MAXY G# 56 INTERCEPT red 56 murine model 56 revascularisation 56 stable angina 55 6R BH4 55 drug eluting coronary stent 55 Spheramine 55 multiple myeloma MM 55 Pulmonary hypertension 55 dirucotide 55 Nanobody 55 polymerase inhibitor 55 calcineurin inhibitors 55 Desmoteplase 55 Aliskiren 55 INTEGRILIN 55 superficial bladder cancer 55 patients undergoing percutaneous 55 hematopoietic cell 55 Allovectin 7 R 55 Phase IIB 55 vasodilators 55 hypoxia inducible factor 55 romiplostim 55 PREZISTA r 55 Cloretazine R VNP#M 55 Pivotal Phase 55 Pioglitazone 55 Proxinium TM 55 olmesartan 55 Telmisartan 55 angina pectoris 55 Chrysalin 55 antithrombotic 55 osteoblast 55 bicifadine

Back to home page